Abstract 1955: Simultaneous longitudinal assessment of PIK3CA genomic mutations and PI3K pathway activity in circulating tumor cells in metastatic breast cancer
Marina N. Sharifi(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Amanda Parkes(University of Wisconsin–Madison), Kyle T. Helzer(University of Wisconsin–Madison), Hannah Krause(University of Wisconsin–Madison), Kari B. Wisinski(University of Wisconsin Carbone Cancer Center), Ruth M. O'Regan(University of Wisconsin Carbone Cancer Center), Mark E. Burkard(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Serena K. Wolfe(University of Wisconsin–Madison), Amyé Tevaarwerk(Mayo Clinic), Cole S. Gilsdorf(University of Wisconsin–Madison), Zachary J. Kauffman(University of Wisconsin–Madison)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592